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ABSTRACT	
	
Aim	
	
A	single-centre,	prospective	longitudinal	study	to	assess	changes	in	maternal	arterial	
stiffness	and	cardiac	output	parameters	among	low-risk	healthy	pregnant	women.		
Methodology	
	
Thirty	low-risk,	healthy,	pregnant	women	attending	their	routine	antenatal	dating	
ultrasound	scan	were	recruited.	Non-invasive	assessment	of	arterial	stiffness	and	cardiac	
output	was	undertaken	at	five	gestational	windows	from	11	to	40	weeks	of	pregnancy.	Data	
were	analysed	using	a	linear	mixed	model	incorporating	time	and	other	relevant	predictors	
as	fixed	effects,	and	patient	as	a	random	effect.		
	
Results	
	
Gestational	age	had	a	significant	effect	on	all	arterial	stiffness	parameters,	including	brachial	
augmentation	index	(AIx)	(p=0.001),	aortic	AIx	(p=0.002)	and	aortic	pulse	wave	velocity	
(p=0.002).	The	aortic	AIx	(%)	reduced	during	pregnancy:	the	lowest	mean	(standard	error,	
SE)	was	4.07	(1.01)	at	28	weeks	before	it	increased	to	7.04	(SE	1.64)	at	40	weeks.	
Similarly,	non-invasive	assessments	of	cardiac	output	(p<0.001),	stroke	volume	(p=0.014),	
heart	rate	(p<0.001)	and	total	peripheral	resistance	(p<0.001)	demonstrated	significant	
changes	with	gestational	age.	Mean	cardiac	output	(l/m)	increased	during	pregnancy	
reaching	a	peak	at	28	weeks	gestation	6.66	(SE	0.28),	but	dropped	thereafter	to	reach	5.71	
(SE	0.25)	around	term.		
Conclusion	
	
The	current	study	provides	pregnancy	normograms	for	gestational	changes	in	arterial	
stiffness	and	cardiac	output	parameters	among	low-risk,	healthy	pregnant	women.	Further	
work	will	be	required	to	assess	the	risk	of	placental	mediated	diseases	and	pregnancy	
outcome	among	pregnant	women	with	parameters	outside	the	normal	range.		
	
	
	
	
	
	
	
	 	
INTRODUCTION	
	
Pregnancy	is	associated	with	significant	cardiovascular	adaptations	to	support	the	
pregnancy,	ensuring	adequate	placental	perfusion	and	foetal	development.	These	changes	
however,	differ	between	normal	and	pathological	pregnancies,	and	do	precede	onset	of	the	
clinical	disorder1,2.		Alterations	in	cardiac	output	(CO)	have	been	associated	with	
hypertensive	diseases	of	pregnancy,	with	an	increased	CO	being	detected	prior	to	the	onset	
of	both	pre-eclampsia	and	gestational	hypertension.3	Moreover,	CO	was	noted	to	be	
reduced	at	the	clinical	manifestation	of	pre-eclampsia4.	
Arterial	stiffness	is	an	independent	predictor	of	cardiovascular	(CV)	mortality	and	morbidity,	
both	in	low	and	high	risk	populations5.	According	to	the	European	Society	of	Hypertension	
(ESH)	and	European	Society	of	Cardiology	guidelines,	pulse	wave	velocity	(PWV)	is	a	useful	
parameter	in	the	stratification	of	CV	risk6.	Increased	systemic	arterial	stiffness	has	been	
reported	among	women	with	hypertensive	disorders	during	pregnancy7-9.It	is	associated	
with	foetal	growth	restriction1	and	may	have	a	role	as	a	potential	screening	tool	in	
pregnancy10.	Scientific	and	clinical	interest	continues	to	grow	in	evaluating	the	role	of	
arterial	stiffness	and	its	association	with	pregnancy	complications	and	cardiovascular	
disorders	during	pregnancy1,9,11.			
A		number	of	studies12-18	have	evaluated	the	longitudinal	pattern	of	arterial	stiffness	during	
pregnancy;	however	only	four	studies13,14,16,18	evaluated	the	same	group	of	women	
longitudinally	through	pregnancy.	Three	studies13,16,18	adopted	applanation	tonometry	
whilst	one	study14	used	an	oscillometric	method	to	evaluate	maternal	haemodynamic	
parameters.		The	remaining	studies	recruited	case	matched	controls	at	various	gestations	in	
pregnancy.	With	this	modest	amount	of	information	available,	it	has	been	identified	that	
PWV	decreases	mid-pregnancy15,17	and	then	increases	non-significantly	in	the	third	
trimester2,12,15,17,	albeit	remaining		within	the	normal	non-pregnant	range.	However,	normal	
limits	for	PWV	in	pregnancy	have	not	been	reported.	Recently,	we	have	examined	
repeatability	and	diurnal	variation	of	maternal	haemodynamics	amongst	healthy	pregnant	
women	in	their	third	trimester19.	
	
Despite	the	wealth	of	literature,	there	remains	a	lack	of	agreement	on	the	longitudinal	
pattern	of	CO	in	pregnancy.	CO	was	reported	to	follow	three	different	patterns	of	change	
throughout	pregnancy;	(1)	a	continued	increase	until	term20-22,	(2)	a	steady	increase,	
peaking	in	the	latter	half	of	pregnancy	with	a	subsequent	decrease	to	term23,24,	(3)	a	steady	
increase,	peaking	in	the	latter	half	of	pregnancy,	with	a	plateau	until	term25-27.	
	
The	aim	of	this	longitudinal	study	was	to	assess,	non-invasively,	changes	in	arterial	stiffness	
and	cardiac	output	parameters	among	low-risk	healthy	pregnant	women	in	order	to	
improve	the	current	understanding	of	normal	cardiac	adaptation	in	pregnant	women	and	to	
provide	normograms.	
	METHODS	
	
This	was	a	prospective	longitudinal	study	of	low-risk,	healthy	pregnant	women	with	a	
singleton	viable	pregnancy.	Consecutive	participants	were	invited	to	join	the	study	following	
attendance	at	their	routine	first	trimester	dating	ultrasound	scan	at	the	University	Hospitals	
of	Leicester	NHS	Trust.	The	study	was	ethically	approved	by	Stanmore	National	Research	
Ethics	Committee,	Reference	12/LO/0810.		Participants	were	excluded	if	they	had:	a	BMI	
>25	at	booking,	multiple	pregnancy,	foetal	anomalies,	pre-pregnancy	hypertension,	
pregnancy	induced	hypertension,	pre-eclampsia,	thyroid	disease	requiring	medication,	renal	
disease,	liver	disease,	congenital	or	acquired	cardiac	condition,	diabetes	mellitus,	were	
taking	any	medication	that	could	affect	the	cardiovascular	system	or	were	current	smokers.	
	
Following	informed	written	consent,	maternal	demographics	were	recorded.			
Non-invasive	assessment	of	arterial	stiffness	(Arteriograph®,	Tensiomed	Ltd,	Hungary)	and	
cardiac	output	(NICOM,	Cheetah	Medical,	Portland,	Oregon)	were	undertaken	at	five	
gestational	windows	between	11	to	40	weeks	of	pregnancy,	in	a	temperature-controlled	
room	(22°C),	in	a	semi-recumbent	position.	Women	were	examined	at	the	following	
gestational	windows;	11-13,	20-22,	26-28,	32-34	and	37-40	weeks	of	pregnancy.	Participants	
were	rested	for	a	minimum	of	ten	minutes	prior	to	non-invasive	haemodynamic	
examination	and	were	free	from	distractions,	including	speaking	and	moving,	during	the	
assessments.	Participants	were	advised	to	avoid	caffeine	intake	on	the	day	of	assessment.		
Arterial	stiffness	measurements,	PWV	and	augmentation	index	(AIx),	were	obtained	with	an	
Arteriograph®.	This	non-invasive	device,	used	to	determine	arterial	stiffness28	,	is	fully	
automated,	and	has	been	validated	against	invasive	and	non-invasive	measurements29,30,	in	
non-pregnant	populations.	Despite	there	being	no	validation	studies	of	the	Arteriograph®	in	
pregnancy,	the	device	has	been	used	on	a	very	large	scale	in	pregnancy	research29,31,32.	The	
accuracy	of	systolic	blood	pressure	(SBP),	PWV	and	AIx	determination	has	been	validated	
against	invasive	monitoring33.	The	Arteriograph®cuff	was	applied	to	the	right	arm	over	the	
brachial	artery	for	an	estimation	of	SBP	(mmHg),	PWV	(m/s)	and	AIx	(%)	as	previously	
described29.		
The	NICOM®	is	an	operator	independent	device	that	has	recently	been	validated	against	
echocardiographic	assessment	in	pregnancy	and	has	demonstrated	excellent	repeatability	
and	reproducibility,	(ICC=0.953,	95%	CI	0.927-0.969,	respectively)34.	After	initial	calibration,	
continuous	values	of	stroke	volume	(SV),	CO	and	total	peripheral	resistance	(TPR)	were	
recorded;	stroke	volume	index	(SVI),	cardiac	Index	(CI)	and	total	peripheral	resistance	index	
(TPRI)	were	determined	by	dividing	each	parameter	by	the	body	surface	area.	
All	recordings	were	made	by	one	professional	(MWO),	who	received	appropriate	training	on	
use	of	the	Arteriograph®	and	NICOM®	devices.		
	
Statistical	analysis	
	
We	modelled	the	changes	in	each	of	the	haemodynamic	measurements,	represented	by	
Arteriograph®	(brachial	and	aortic	AIx,	PWV)	and	NICOM®	(CO,	CI,	SV,	SVI,	HR)	assessment,	
by	separate	linear	mixed	models	incorporating	gestational	age	(GA)	as	a	fixed	effect.	We	
tested	the	statistical	significance	(p<0.05)	of	linear,	quadratic	and	cubic	terms	of	GA	with	
haemodynamic	measurements.	The	final	models	for	brachial	and	aortic	AIx	also	included	
heart	rate,	central	mean	arterial	BP	as	additional	fixed	effects.	All	models	included	a	random	
intercept	of	individual,	and	if	statistically	significant	(p<0.05),	a	random	time-specific	slope	
for	each	individual.	All	continuous	variables	were	included	in	the	model	as	a	deviation	from	
the	population	means.	The	final	fitted	model	for	each	haemodynamic	measurement	was	
used	to	predict	means	and	corresponding	95%	confidence	intervals,	as	well	as	different	
percentiles	(5th,	25th,	50th,	75th,	95th),	across	different	points	of	GA.		
All	fitted	models	were	checked	for	their	underlying	model	assumptions.	The	model	selection	
within	a	set	of	candidate	models	was	assessed	by	comparing	the	log-likelihood	of	the	nested	
models	along	with	Akaike	information	criterion	and	Schwarz	Bayesian	information	criterion.	
All	statistical	tests	were	two-sided	with	type	1	error	rate	(p-value)	of	0.05	to	determine	the	
statistical	significance.	All	statistical	analyses	were	carried	out	using	the	R	software	version	
3.3	with	appropriate	R	packages	(nlme,	multcomp,	ggplot2)	(R	Core	Team,	2016).	
RESULTS	
	
Thirty	healthy	low-risk	pregnant	women	fulfilled	the	inclusion	and	exclusion	criteria	and	
were	recruited	to	the	study.	Table	1	summarises	the	demographic	details	of	our	study	
population.		
Arterial	Stiffness	
Significant	changes	in	all	measurements	of	arterial	stiffness	were	seen	during	healthy	
pregnancy	(Table	2	and	Supplementary	Table	1).	Both	brachial	and	aortic	AIx	reduced	during	
early	pregnancy,	reached	a	nadir	at	28	weeks,	before	increasing	towards	40	weeks	of	
gestation	(Table	2,	Figure	1).	Both	demonstrated	a	quadratic	relationship	with	GA.	The	
aortic	PWV	also	showed	a	significant	variation	during	the	pregnancy:	the	pattern	was	
however	more	complex	showing	a	cubic	relationship	with	GA.	(Table	2,	Figure	1).	PWV	
reached	its	lowest	value	at	17	weeks	of	gestation	and	then	increased,	reaching	a	peak	at	35	
weeks	gestation.	AIx	reached	its	lowest	point	at	mid-pregnancy	(28	weeks)	and	then	
gradually	increased	towards	the	term.	Mean	arterial	BP	and	heart	rate	were	significantly	
associated	with	measures	of	arterial	stiffness	(Table	3).	Mean	arterial	BP	demonstrated	a	
strong	positive	association	(p<0.001)	while	heart	rate	showed	a	strong	negative	association	
(p<0.001)	with	AIx.	Estimated	effects	(standard	error,	SE)	for	mean	arterial	BP	were	0.36	
(0.05)	and	0.67	(0.10)	for	aortic	AIx	and	brachial	AIx,	respectively,	while	those	for	heart	rate	
were	-0.25	(0.05)	and	-0.49	(0.10)	for	aortic	and	brachial	AIx,	respectively.		
Cardiac	output	parameters	
	
CO	and	CI	demonstrated	significant	changes	(p<0.001)	across	GA	(Table	2,	Figure	2).	SV	also	
showed	a	significant	(p=0.013)	change	with	GA;	progressively	reducing	between	weeks	13	
and	40	of	healthy	pregnancy	(Table	2,	Figure	2,	Supplementary	Table	2).		
Mean	TPR	value	also	changed	significantly	with	GA	(p=0.011).	The	relationship	of	GA	with	
TPR	was	quadratic	in	form.	Mean	TPR	declined	initially	with	advancing	GA	reaching	the	
lowest	value	around	22	weeks,	and	then	increased	at	subsequent	time	points	(Figure	2).	
HR	also	showed	a	significant	quadratic	relationship	with	GA	(p<0.001).	Mean	HR	values	
initially	increased	with	GA,	reaching	its	highest	value	around	the	30th	week,	and	thereafter	
decreased	until	term	(Figure	2).		
DISCUSSION	
	
This	study	has	demonstrated	that	normal	pregnancy	is	associated	with	significant	alterations	
in	the	maternal	cardiovascular	system,	as	demonstrated	by	the	pattern	of	arterial	stiffness	
and	NICOM	measurements,	with	GA	having	a	significant	effect	on	maternal	
haemodynamics.	Using	the	linear	mixed	modelling	framework,	we	were	able	to	provide	
normograms	for	arterial	stiffness	and	non-invasive	CO	parameters	in	healthy	low-risk	
women,	which	have	not	been	previously	reported.		
Our	study	establishes	that	in	normal	pregnancy,	AIx	demonstrates	a	gradual	decline	in	early	
pregnancy,	reaching	its	lowest	value	at	around	28	weeks	of	gestation,	and	then	increases	
with	advancing	GA	to	term.		This	is	in	agreement	with	previous	reports13,16,35.		The	pattern	of	
AIx	in	the	present	study	suggests	that	maternal	circulatory	adaptation	is	completed	after	the	
first	trimester	and	remains	constant	through	the	second	trimester.		
PWV	demonstrated	a	more	complex	pattern,	grossly	resembling	a	sine	wave.	There	was	an	
initial	decline	to	17	weeks	of	gestation,	increasing	up	to	35	weeks	and	subsequently	
declining	again.	This	is	similar	to	studies	that	have	identified	that	PWV	decreases	mid-
pregnancy15,17	and	then	increases	non-significantly	in	the	third	trimester2,12,15,17	.		However,	
it	differs	from	Macedo	and	colleagues	who	observed	that	PWV	(carotid-radial	and	carotid-
femoral)	did	not	change	significantly	with	gestation	and	was	marginally	different	between	
pregnant	and	non-pregnant	women16.	Normal	limits	for	PWV	in	pregnancy	have	not	been	
established.	However,		in	healthy	non-pregnant	women	the	normal	limit	is	10m/s36.	Our	
overall	mean	PWV	of	7.81	m/s	is	significantly	lower	than	that	expected	in	non-pregnant	
women.	Several	investigators	proposed	different	mechanisms	to	explain	the	drop	of	PWV	in	
the	first	trimester	of	pregnancy.	It	may	be	due	to	the	alterations	of	vaso-active	substances	
such	as	nitric	oxide	(NO)37,38,	progesterone,	relaxin,	as	well	as	related	to	volume	expansion	
in	pregnancy13.	The	subsequent	rise	from	the	mid-trimester	of	pregnancy	to	term	could	be	
due	to	the	inhibition	of	NO39,40,	increase	in	cardiac	output41	and	increased	circulatory	
volume41.	
Similarly,	NICOM	parameters	also	demonstrated	a	significant	variation	over	the	duration	of	
pregnancy.	It	is	understood	that	over	the	first	two	trimesters	of	pregnancy,	CO	gradually	
increases	with	the	greatest	increase	occurring	by	16	weeks	of	gestation42-44.	The	rise	in	CO	is	
believed	to	plateau	after	20	weeks	of	gestation	but	remains	at	that	elevated	level	until	
term21,43.		The	increase	in	the	heart	rate	and	SV	contribute	to	this	increase	in	CO45.	However,	
we	noted	that	CO	reached	a	peak	at	around	28	weeks	of	gestation	and	then	declined	to	
term.	Changes	in	heart	rate	within	our	study	population,	mirrored	previous	observations	by	
others45	and	was	the	main	influence	in	the	pattern	of	CO.	
The	resistance	offered	by	the	systemic	circulation	is	either	called	systemic	vascular	
resistance	(SVR)	or	TPR.	It	is	understood	that	from	the	5th	week	of	pregnancy,	there	is	a	
decline	in	SVR/TPR,	which	reaches	a	nadir	between	weeks	20	and	32	weeks25,46.	There	is	
then	a	gradual	increase	in	SVR	from	32	weeks	until	term25,46.		In	this	study	the	mean	TPR	
declined	initially	with	increased	GA	reaching	the	lowest	value	around	22	weeks,	and	then	it	
increased	as	pregnancy	advanced	to	term.	The	pattern	of	a	reduction	in	SVR	is	due	to	
changes	in	resistance	and	flow	in	multiple	vascular	beds,	such	as	the	utero-placental	unit.	
These	changes	are	necessary	to	allow	maternal	adaptation	to	the	gravid	uterus	and	promote	
the	delivery	of	oxygen	and	nutrients	to	the	foetus44.		
Most	studies	explored	maternal	haemodynamics	in	women	affected	with	medical	conditions	
in	pregnancy.	However,	in	this	longitudinal	study,	the	thirty	participants	were	required	to	
meet	stringent	selection	criteria	to	ensure	that	all	variables	such	as	a	raised	BMI,	smoking	or	
medical	conditions9,16	(pre-eclampsia,	diabetes)	that	may	influence	maternal	haemodynamic	
parameters	were	eliminated.	Furthermore,	the	women	remained	low	risk	throughout	
pregnancy	and	did	not	develop	any	medical	conditions	that	may	influence	maternal	
haemodynamics.	Arterial	stiffness	and	NICOM	measurements	are	usually	performed	in	the	
supine	position.	However,	in	the	present	study,	all	measurements	were	performed	in	the	
left	lateral	position	to	avoid	vena	cava	compression	by	the	uterus.	Therefore,	the	results	
obtained	in	this	study	are	a	good	benchmark	for	normal	values	in	pregnancy.	Every	effort	
was	made	to	reduce	selection	bias	in	our	study	as	women	were	recruited	when	attending	a	
dating	scan,	rather	than	from	a	specific	clinic.	This	increased	the	likelihood	of	women	from	a	
wider	population	being	recruited.	A	limitation	of	our	study	is	the	small	number	of	
participants	(n=30),	however,	an	attempt	to	overcome	this	was	made	with	the	longitudinal	
design	of	this	study	in	which	the	women	were	investigated	on	five	separate	occasions.		
The	findings	of	this	study	offer	a	significant	breakthrough	in	the	established	knowledge	of	
maternal	haemodynamics	and	provides	a	new	insight	into	the	maternal	adaptation	to	
pregnancy	and	may	prove	useful	for	future	research	as	well	as	in	clinical	use.	
	
CONCLUSION	
	
The	current	study	provides	pregnancy	normograms	for	gestational	changes	in	arterial	
stiffness	and	non-invasive	CO	parameters	among	low-risk,	healthy	pregnant	women.	Further	
works	will	be	required	to	assess	the	risk	of	placental	mediated	diseases	and	pregnancy	
outcome	among	pregnant	women	with	parameters	outside	the	normal	pregnancy	range.		
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FIGURE	LEGENDS	
	
Figure	1:	Relationship	of	gestational	age	with	brachial	augmentation	index	(Br	AIx),	aortic	
augmentation	index	(Ao	AIx),	pulse	wave	velocity	(PWV)	and	central	mean	arterial	pressure	
(CMAP)	measurements,	based	on	the	fitted	linear	mixed	model.	Lines	represent	5th,	25th,	
50th,	75th	and	95th	percentiles,	and	points	represent	the	observed	data	for	each	patient.			
	
Figure	2:	The	relationship	of	gestational	age	with	cardiac	output	(CO),	stroke	volume	(SV),	
total	peripheral	resistance	(TPR)	and	Heart	rate	(HR)	measurements,	based	on	the	fitted	
linear	mixed	model.	Lines	represent	5th,	25th,	50th,	75th	and	95th	percentiles,	and	points	
represent	the	observed	data	for	each	patient.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Table	1:	Estimated	mean	(standard	deviation)	of	different	demographic	variables	of	the	
study	population		
Demographic	characteristics	 Mean	(Standard	deviation)	
Maternal	age,	years	 28.8	(4.2)	
Body	Surface	Area	(m2)	 1.64	(0.13)	
Maternal	height	(cm)		 163.2	(7.4)	
Maternal	weight	(kg)		 59.9	(8.4)	
Maternal	body	mass	index	
(kg/m2)	
22.1	(2.6)	
Parity	 Nulliparous		 14	(47%)	
	 Multiparous	 16	(53%)	
Ethnicity	 Caucasian	 27	(90%)	
	
Asian	 2	(7%)	
Middle-eastern	 1	(3%)	
	
	
Table	2:	Predicted	mean	(95%	lower,	upper	confidence	interval)	of	arterial	stiffness	and	cardiac	output	measurements	at	five	time	points	
(13,	20,	28,	34	and	40	weeks)	of	gestational	age	(GA)	obtained	from	the	fitted	linear	mixed	model.	The	table	also	presents	the	relationship	
of	haemodynamic	measurements	with	GA	and	corresponding	statistical	significance	(p-value).		
Gestational	age	
Brachial	Aix	
	
Aortic	Aix	
	
Aortic	
PWV	
	
Cardiac	
Output	
	
Cardiac	
Index	
	
	
Stroke	
volume	
	
Total	peripheral	
resistance	
	
Heart	rate	
Mean		
Arterial		
Blood		
Pressure	
%	 %	 m/s	 l/min	 l/min/m2	 ml	 dynes.sec/cm5	 Beats/min	 mmHg	
13	weeks	 -54.57		
(-59.92,	-
49.21)	
9.90		
(7.34,	
12.46)	
7.50		
(7.07,	
7.92)	
6.34		
(5.79,	6.89)	
3.89		
(3.58,	4.19)	
76.74		
(70.51,	82.97)	
1146.57		
(1046.28,		
1256.46)	
83.11		
(78.67,	87.55)	
58.27	
(54.65,	
62.12)	
20	weeks	 -63.05		
(-66.96,	-
59.15)	
5.83		
(3.89,	7.77)	
7.27		
(6.88,	
7.66)	
6.39		
(5.92,	6.85)	
3.87		
(3.62,	4.12)	
74.08		
(69.36,	78.80)	
1091.08		
(1025.98,		
1160.31)	
90.12		
(86.47,	93.78)	
57.65	
(54.32,	
61.18)	
28	weeks	 -66.5	
(-70.35,	-
62.65)	
4.07		
(2.08,	6.06)	
7.94		
(7.6,	
8.28)	
6.66		
(6.23,	7.09)	
4.05		
(3.82,	4.27)	
71.05		
(67.35,	74.75)	
1110.75		
(1044.5,	
	1181.21)	
93.42		
(89.57,	97.28)	
57.39	
(54.36,	
60.59)	
34	weeks	 -64.71		
(-68.51,	-
60.92)	
4.76		
(2.95,	6.58)	
8.33		
(7.97,	
8.7)	
6.53		
(6.09,	6.96)	
3.98		
(3.75,	4.21)	
68.77		
(64.97,	72.57)	
1186.06		
(1120.91,		
1255)	
92.6		
(88.93,	96.27)	
62.85	
(59.37.	
66.53)	
40	weeks	 -59.17		
(-65.88,	-
52.46)	
7.19		
(3.99,	10.4)	
8.02		
(7.48,	
8.55)	
5.71		
(5.22,	6.20)	
3.48		
(3.21,	3.75)	
66.5		
(61.88,	71.12)	
1324.42		
(1233.22,	
	1422.36)	
88.94		
(83.84,	94.04)	
80.28	
(74.40,	
86.62)	
Relationship	
with	GA	
Quadratic	 Quadratic	 Cubic	 Cubic	 Cubic	 Linear	 Quadratic	 Quadratic	 Quadratic	
p-value	 0.001	 0.002	 0.002	 <0.001	 <0.001	 0.013	 0.011	 <0.001	 0.023	
	
Augmentation	index	(AIx),	pulse	wave	velocity	(PWV).
Table	3:	Normograms	representing	estimated	means	and	standard	deviations	of	arterial	
stiffness	measurements,	brachial	augmentation	index	(BrAIX),	aorta	augmentation	index	
(AoAIX),	and	pulse	wave	velocity	(PWV),	at	weekly	time	intervals	from	13	to	40	weeks	of	
gestational	age	(GA).		
	 BrAIX	 AoAIX	 PWV	
GA	
(weeks)	
Mean		
(%)	 SD	
Mean	
(%)	 SD	
Mean	
(m/s)	 SD	
13	 -54.57	 13.44	 9.90	 6.44	 7.50	 1.13	
14	 -56.09	 13.24	 9.35	 6.44	 7.38	 1.13	
15	 -57.51	 13.05	 8.66	 6.44	 7.30	 1.13	
16	 -58.83	 12.88	 8.02	 6.44	 7.25	 1.13	
17	 -60.04	 12.72	 7.43	 6.44	 7.22	 1.13	
18	 -61.15	 12.57	 6.88	 6.44	 7.22	 1.13	
19	 -62.15	 12.44	 6.39	 6.44	 7.23	 1.13	
20	 -63.05	 12.33	 5.94	 6.44	 7.27	 1.13	
21	 -63.85	 12.24	 5.54	 6.44	 7.32	 1.13	
22	 -64.54	 12.16	 5.18	 6.44	 7.39	 1.13	
23	 -65.13	 12.09	 4.88	 6.44	 7.47	 1.13	
24	 -65.61	 12.05	 4.62	 6.44	 7.56	 1.13	
25	 -65.99	 12.02	 4.41	 6.44	 7.65	 1.13	
26	 -66.27	 12.01	 4.25	 6.44	 7.75	 1.13	
27	 -66.44	 12.02	 4.14	 6.44	 7.84	 1.13	
28	 -66.50	 12.05	 4.08	 6.44	 7.94	 1.13	
29	 -66.47	 12.09	 4.06	 6.44	 8.03	 1.13	
30	 -66.32	 12.16	 4.09	 6.44	 8.12	 1.13	
31	 -66.08	 12.23	 4.17	 6.44	 8.19	 1.13	
32	 -65.73	 12.33	 4.30	 6.44	 8.25	 1.13	
33	 -65.27	 12.44	 4.48	 6.44	 8.30	 1.13	
34	 -64.71	 12.57	 4.70	 6.44	 8.33	 1.13	
35	 -64.05	 12.72	 4.97	 6.44	 8.35	 1.13	
36	 -63.28	 12.88	 5.29	 6.44	 8.34	 1.13	
37	 -62.41	 13.05	 5.66	 6.44	 8.30	 1.13	
38	 -61.44	 13.24	 6.08	 6.44	 8.24	 1.13	
39	 -60.36	 13.44	 6.54	 6.44	 8.14	 1.13	
40	 -59.17	 13.65	 7.06	 6.44	 8.02	 1.13	
	
	
	
	
Table	4:	Normograms	representing	estimated	means	and	standard	deviations	of	cardiac	
output	measurements,	cardiac	output,	stroke	volume	and	heart	rate,	at	weekly	time	
interval	from	13	to	40	weeks	of	gestational	age	(GA).	
	 Cardiac	output	 Stroke	volume	 Heart	rate	
GA	
(weeks)	
Mean	
(L/min)	 SD	
Mean	
(ml)	 SD	
Mean	
(BPM)	 SD	
13	 6.34	 1.51	 76.74	 10.49	 83.11	 12.36	
14	 6.31	 1.48	 76.36	 10.41	 84.35	 12.36	
15	 6.30	 1.45	 75.98	 10.33	 85.51	 12.36	
16	 6.30	 1.43	 75.60	 10.25	 86.59	 12.36	
17	 6.31	 1.40	 75.22	 10.17	 87.59	 12.36	
18	 6.33	 1.38	 74.84	 10.09	 88.51	 12.36	
19	 6.35	 1.37	 74.46	 10.01	 89.36	 12.36	
20	 6.39	 1.35	 74.08	 9.93	 90.12	 12.36	
21	 6.42	 1.34	 73.70	 9.84	 90.81	 12.36	
22	 6.46	 1.32	 73.33	 9.76	 91.42	 12.36	
23	 6.50	 1.31	 72.95	 9.68	 91.95	 12.36	
24	 6.54	 1.30	 72.57	 9.59	 92.40	 12.36	
25	 6.58	 1.29	 72.19	 9.50	 92.78	 12.36	
26	 6.61	 1.28	 71.81	 9.42	 93.07	 12.36	
27	 6.64	 1.27	 71.43	 9.33	 93.29	 12.36	
28	 6.66	 1.26	 71.05	 9.24	 93.42	 12.36	
29	 6.67	 1.25	 70.67	 9.15	 93.48	 12.36	
30	 6.67	 1.24	 70.29	 9.06	 93.46	 12.36	
31	 6.66	 1.24	 69.91	 8.97	 93.36	 12.36	
32	 6.63	 1.23	 69.53	 8.88	 93.19	 12.36	
33	 6.59	 1.22	 69.15	 8.78	 92.93	 12.36	
34	 6.53	 1.22	 68.77	 8.69	 92.60	 12.36	
35	 6.45	 1.21	 68.39	 8.59	 92.18	 12.36	
36	 6.35	 1.21	 68.01	 8.50	 91.69	 12.36	
37	 6.23	 1.20	 67.64	 8.40	 91.12	 12.36	
38	 6.08	 1.20	 67.26	 8.30	 90.47	 12.36	
39	 5.91	 1.19	 66.88	 8.20	 89.75	 12.36	
40	 5.71	 1.19	 66.50	 8.10	 88.94	 12.36	
	
	
	
	
	
	
		
	
	
	
Figure	1:	Relationship	of	gestational	age	with	brachial	augmentation	index	(Br	AIx),	aortic	
augmentation	index	(Ao	AIx),	pulse	wave	velocity	(PWV)	and	central	mean	arterial	pressure	
(CMAP)	measurements,	based	on	the	fitted	linear	mixed	model.	Lines	represent	5th,	25th,	
50th,	75th	and	95th	percentiles,	and	points	represent	the	observed	data	for	each	patient.			
	
		
	
	
Figure	2:	The	relationship	of	gestational	age	with	cardiac	output	(CO),	stroke	volume	(SV),	
total	peripheral	resistance	(TPR)	and	Heart	rate	(HR)	measurements,	based	on	the	fitted	
linear	mixed	model.	Lines	represent	5th,	25th,	50th,	75th	and	95th	percentiles,	and	points	
represent	the	observed	data	for	each	patient.	
	
	
	
	
	
	
	
	
Supplementary	table	1:	Estimates	of	mean,	standard	deviation	and	percentiles	of	aortic	augmentation	index	(Ao	AIx)	and	pulse	wave	
velocity	(PWV)	at	weekly	time	points	from	13	to	40	weeks	of	gestation	
Ao	AIx	 	 PWV	
GA	 Mean	 SD	 5th_PC	 25th_PC	 50th_PC	 75th_PC	 95th_PC	 	 Mean	 SD	 5th_PC	 25th_PC	 50th_PC	 75th_PC	 95th_PC	
13	 9.90	 6.44	 -0.69	 5.56	 9.90	 14.25	 20.50	 	 7.50	 1.13	 5.64	 6.73	 7.50	 8.26	 9.35	
14	 9.18	 6.44	 -1.42	 4.83	 9.18	 13.52	 19.77	 	 7.38	 1.13	 5.52	 6.62	 7.38	 8.14	 9.24	
15	 8.50	 6.44	 -2.10	 4.15	 8.50	 12.84	 19.09	 	 7.30	 1.13	 5.44	 6.54	 7.30	 8.06	 9.16	
16	 7.87	 6.44	 -2.73	 3.52	 7.87	 12.21	 18.46	 	 7.25	 1.13	 5.39	 6.48	 7.25	 8.01	 9.10	
17	 7.29	 6.44	 -3.31	 2.94	 7.29	 11.63	 17.88	 	 7.22	 1.13	 5.36	 6.46	 7.22	 7.98	 9.08	
18	 6.75	 6.44	 -3.84	 2.41	 6.75	 11.10	 17.35	 	 7.22	 1.13	 5.36	 6.45	 7.22	 7.98	 9.07	
19	 6.27	 6.44	 -4.33	 1.92	 6.27	 10.61	 16.86	 	 7.23	 1.13	 5.38	 6.47	 7.23	 8.00	 9.09	
20	 5.83	 6.44	 -4.76	 1.49	 5.83	 10.18	 16.43	 	 7.27	 1.13	 5.41	 6.51	 7.27	 8.03	 9.13	
21	 5.44	 6.44	 -5.15	 1.10	 5.44	 9.79	 16.04	 	 7.32	 1.13	 5.47	 6.56	 7.32	 8.09	 9.18	
22	 5.10	 6.44	 -5.49	 0.76	 5.10	 9.45	 15.70	 	 7.39	 1.13	 5.53	 6.63	 7.39	 8.15	 9.25	
23	 4.81	 6.44	 -5.79	 0.47	 4.81	 9.15	 15.40	 	 7.47	 1.13	 5.61	 6.71	 7.47	 8.23	 9.33	
24	 4.56	 6.44	 -6.03	 0.22	 4.56	 8.91	 15.16	 	 7.56	 1.13	 5.70	 6.80	 7.56	 8.32	 9.41	
25	 4.37	 6.44	 -6.23	 0.02	 4.37	 8.71	 14.96	 	 7.65	 1.13	 5.79	 6.89	 7.65	 8.41	 9.51	
26	 4.22	 6.44	 -6.37	 -0.12	 4.22	 8.56	 14.81	 	 7.75	 1.13	 5.89	 6.99	 7.75	 8.51	 9.60	
27	 4.12	 6.44	 -6.48	 -0.22	 4.12	 8.46	 14.71	 	 7.84	 1.13	 5.99	 7.08	 7.84	 8.61	 9.70	
28	 4.07	 6.44	 -6.53	 -0.28	 4.07	 8.41	 14.66	 	 7.94	 1.13	 6.08	 7.18	 7.94	 8.70	 9.80	
29	 4.06	 6.44	 -6.53	 -0.28	 4.06	 8.41	 14.66	 	 8.03	 1.13	 6.17	 7.27	 8.03	 8.79	 9.89	
30	 4.11	 6.44	 -6.49	 -0.24	 4.11	 8.45	 14.70	 	 8.12	 1.13	 6.26	 7.35	 8.12	 8.88	 9.97	
31	 4.20	 6.44	 -6.40	 -0.15	 4.20	 8.54	 14.79	 	 8.19	 1.13	 6.33	 7.43	 8.19	 8.95	 10.05	
32	 4.34	 6.44	 -6.26	 0.00	 4.34	 8.68	 14.93	 	 8.25	 1.13	 6.40	 7.49	 8.25	 9.02	 10.11	
33	 4.53	 6.44	 -6.07	 0.18	 4.53	 8.87	 15.12	 	 8.30	 1.13	 6.45	 7.54	 8.30	 9.06	 10.16	
34	 4.76	 6.44	 -5.83	 0.42	 4.76	 9.11	 15.36	 	 8.33	 1.13	 6.48	 7.57	 8.33	 9.10	 10.19	
35	 5.05	 6.44	 -5.55	 0.70	 5.05	 9.39	 15.64	 	 8.35	 1.13	 6.49	 7.58	 8.35	 9.11	 10.20	
36	 5.38	 6.44	 -5.21	 1.04	 5.38	 9.73	 15.98	 	 8.34	 1.13	 6.48	 7.57	 8.34	 9.10	 10.19	
37	 5.76	 6.44	 -4.83	 1.42	 5.76	 10.11	 16.36	 	 8.30	 1.13	 6.44	 7.54	 8.30	 9.06	 10.16	
38	 6.19	 6.44	 -4.40	 1.85	 6.19	 10.54	 16.79	 	 8.24	 1.13	 6.38	 7.48	 8.24	 9.00	 10.10	
39	 6.67	 6.44	 -3.93	 2.32	 6.67	 11.01	 17.26	 	 8.14	 1.13	 6.29	 7.38	 8.14	 8.91	 10.00	
40	 7.19	 6.44	 -3.40	 2.85	 7.19	 11.54	 17.79	 	 8.02	 1.13	 6.16	 7.26	 8.02	 8.78	 9.88	
Supplementary	table	2:	Estimates	of	mean,	standard	deviation	and	percentiles	of	cardiac	output	(CO)	and	stroke	volume	(SV)	at	weekly	
time	points	from	13	to	40	weeks	of	gestation	
Cardiac	Output	 	 Stroke	volume	
GA	 Mean	 SD	 5th_PC	 25th_PC	 50th_PC	 75th_PC	 95th_PC	 	 Mean	 SD	 5th_PC	 25th_PC	 50th_PC	 75th_PC	 95th_PC	
13	 6.34	 1.51	 3.86	 5.32	 6.34	 7.36	 8.82	 	 76.74	 10.49	 59.48	 69.66	 76.74	 83.82	 94.00	
14	 6.31	 1.48	 3.88	 5.32	 6.31	 7.31	 8.74	 	 76.36	 10.41	 59.23	 69.34	 76.36	 83.38	 93.49	
15	 6.30	 1.45	 3.91	 5.32	 6.30	 7.28	 8.69	 	 75.98	 10.33	 58.98	 69.01	 75.98	 82.95	 92.98	
16	 6.30	 1.43	 3.95	 5.34	 6.30	 7.26	 8.64	 	 75.60	 10.25	 58.74	 68.69	 75.60	 82.52	 92.47	
17	 6.31	 1.40	 4.00	 5.36	 6.31	 7.25	 8.62	 	 75.22	 10.17	 58.49	 68.36	 75.22	 82.08	 91.95	
18	 6.33	 1.38	 4.05	 5.39	 6.33	 7.26	 8.60	 	 74.84	 10.09	 58.24	 68.04	 74.84	 81.65	 91.44	
19	 6.35	 1.37	 4.11	 5.43	 6.35	 7.28	 8.60	 	 74.46	 10.01	 58.00	 67.71	 74.46	 81.21	 90.93	
20	 6.39	 1.35	 4.17	 5.48	 6.39	 7.30	 8.61	 	 74.08	 9.93	 57.76	 67.39	 74.08	 80.78	 90.41	
21	 6.42	 1.34	 4.23	 5.52	 6.42	 7.32	 8.62	 	 73.70	 9.84	 57.51	 67.07	 73.70	 80.34	 89.90	
22	 6.46	 1.32	 4.29	 5.57	 6.46	 7.35	 8.64	 	 73.33	 9.76	 57.27	 66.74	 73.33	 79.91	 89.38	
23	 6.50	 1.31	 4.35	 5.62	 6.50	 7.39	 8.66	 	 72.95	 9.68	 57.03	 66.42	 72.95	 79.47	 88.86	
24	 6.54	 1.30	 4.41	 5.67	 6.54	 7.42	 8.68	 	 72.57	 9.59	 56.79	 66.10	 72.57	 79.03	 88.34	
25	 6.58	 1.29	 4.46	 5.71	 6.58	 7.45	 8.70	 	 72.19	 9.50	 56.56	 65.78	 72.19	 78.60	 87.82	
26	 6.61	 1.28	 4.51	 5.75	 6.61	 7.47	 8.71	 	 71.81	 9.42	 56.32	 65.46	 71.81	 78.16	 87.30	
27	 6.64	 1.27	 4.55	 5.78	 6.64	 7.49	 8.72	 	 71.43	 9.33	 56.08	 65.14	 71.43	 77.72	 86.77	
28	 6.66	 1.26	 4.59	 5.81	 6.66	 7.51	 8.73	 	 71.05	 9.24	 55.85	 64.82	 71.05	 77.28	 86.25	
29	 6.67	 1.25	 4.61	 5.82	 6.67	 7.51	 8.73	 	 70.67	 9.15	 55.62	 64.50	 70.67	 76.84	 85.72	
30	 6.67	 1.24	 4.62	 5.83	 6.67	 7.51	 8.71	 	 70.29	 9.06	 55.39	 64.18	 70.29	 76.40	 85.19	
31	 6.66	 1.24	 4.62	 5.82	 6.66	 7.49	 8.69	 	 69.91	 8.97	 55.16	 63.86	 69.91	 75.96	 84.66	
32	 6.63	 1.23	 4.61	 5.80	 6.63	 7.46	 8.65	 	 69.53	 8.88	 54.93	 63.54	 69.53	 75.52	 84.13	
33	 6.59	 1.22	 4.57	 5.76	 6.59	 7.41	 8.60	 	 69.15	 8.78	 54.70	 63.23	 69.15	 75.08	 83.60	
34	 6.53	 1.22	 4.52	 5.71	 6.53	 7.35	 8.53	 	 68.77	 8.69	 54.48	 62.91	 68.77	 74.63	 83.07	
35	 6.45	 1.21	 4.45	 5.63	 6.45	 7.27	 8.44	 	 68.39	 8.59	 54.26	 62.60	 68.39	 74.19	 82.53	
36	 6.35	 1.21	 4.36	 5.53	 6.35	 7.16	 8.33	 	 68.01	 8.50	 54.04	 62.28	 68.01	 73.75	 81.99	
37	 6.23	 1.20	 4.25	 5.41	 6.23	 7.04	 8.20	 	 67.64	 8.40	 53.82	 61.97	 67.64	 73.30	 81.45	
38	 6.08	 1.20	 4.11	 5.27	 6.08	 6.89	 8.05	 	 67.26	 8.30	 53.60	 61.66	 67.26	 72.86	 80.91	
39	 5.91	 1.19	 3.95	 5.10	 5.91	 6.71	 7.87	 	 66.88	 8.20	 53.38	 61.34	 66.88	 72.41	 80.37	
40	 5.71	 1.19	 3.75	 4.91	 5.71	 6.51	 7.66	 	 66.50	 8.10	 53.17	 61.03	 66.50	 71.96	 79.82	
	
